Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Are We Underestimating VTE After PanNET Surgery? – RPTH Journal
RPTH Journal/LinkedIn
Apr 16, 2026, 18:27

Are We Underestimating VTE After PanNET Surgery? – RPTH Journal

RPTH Journal shared a post on LinkedIn about a recent article by Kelly Dong et al:

”Postoperative VTE in pancreatic neuroendocrine tumors. Are we underestimating risk?

A large NSQIP analysis (n=60,649) examined VTE after pancreatectomy for pNENs vs other histologies.

Key findings:

  • Overall VTE risk is similar to other pancreatic cancers (approximately 3.6%)
  • But DVT risk is higher in pNEN vs PDAC (adjusted OR approximately 1.25)
  • PE risk is not significantly different

What drives VTE in pNEN?

Independent risk factors include:

  • Increased BMI
  • Pre-op transfusion
  • Longer operative tim
  • Total pancreatectomy
  • Longer hospital stay

Interpretation:

Despite being perceived as ‘less aggressive’ tumors, pNEN patients carry a meaningful thrombotic burden, particularly for DVT.

This is clinically important because:

  • Guidelines for extended prophylaxis in pNEN are unclear
  • Tumor heterogeneity may mask high-risk subgroups
  • Surgical complexity still drives thrombosis risk”

Title: Venous thromboembolism following surgery for pancreatic neuroendocrine neoplasms

Authors: Kelly Dong, Yasmin Essaji, Caitlin W. Hicks, Elliott R. Haut, Michail N. Mavros

Are We Underestimating VTE After PanNET Surgery? - RPTH Journal

Stay updated on all scientific advances with Hemostasis Today.

Caitlin W. Hicks DVT Elliott R. Haut Hematology Hemostasis News Hemostasis Today Kelly Dong Medicine Michail N. Mavros neuroendocrine pNEN thrombosis VTE Yasmin Essaji
NewsFeed